INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Overview
NYSE:INSP - US4577301090 - Common Stock
INSP Key Statistics, Chart & Performance
The current stock price of INSP is 92.3 USD. In the past month the price decreased by -29.65%. In the past year, price decreased by -48.67%.
INSP Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 26.83 | 228.80B | ||
| ISRG | INTUITIVE SURGICAL INC | 58.53 | 168.90B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.41 | 156.87B | ||
| SYK | STRYKER CORP | 30.6 | 150.31B | ||
| MDT | MEDTRONIC PLC | 16.65 | 117.94B | ||
| BDX | BECTON DICKINSON AND CO | 13.69 | 56.01B | ||
| IDXX | IDEXX LABORATORIES INC | 53.36 | 51.27B | ||
| EW | EDWARDS LIFESCIENCES CORP | 31.48 | 47.50B | ||
| RMD | RESMED INC | 29.52 | 41.28B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.94 | 33.90B | ||
| DXCM | DEXCOM INC | 44.93 | 29.95B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.58 | 26.66B |
Related stock screener links
About INSP
Company Profile
Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The company is headquartered in Golden Valley, Minnesota and currently employs 1,246 full-time employees. The company went IPO on 2018-05-03. The firm is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The firm sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Company Info
INSPIRE MEDICAL SYSTEMS INC
5500 Wayzata Blvd Ste 1600
Golden Valley MINNESOTA 55416 US
CEO: TimothyP. Herbert
Employees: 1246
Phone: 17639575037
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
What is the stock price of INSPIRE MEDICAL SYSTEMS INC today?
The current stock price of INSP is 92.3 USD. The price increased by 0.6% in the last trading session.
What is the ticker symbol for INSPIRE MEDICAL SYSTEMS INC stock?
The exchange symbol of INSPIRE MEDICAL SYSTEMS INC is INSP and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is INSP stock listed?
INSP stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for INSPIRE MEDICAL SYSTEMS INC stock?
26 analysts have analysed INSP and the average price target is 151.2 USD. This implies a price increase of 63.82% is expected in the next year compared to the current price of 92.3. Check the INSPIRE MEDICAL SYSTEMS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is INSPIRE MEDICAL SYSTEMS INC worth?
INSPIRE MEDICAL SYSTEMS INC (INSP) has a market capitalization of 2.73B USD. This makes INSP a Mid Cap stock.
How many employees does INSPIRE MEDICAL SYSTEMS INC have?
INSPIRE MEDICAL SYSTEMS INC (INSP) currently has 1246 employees.
What are the support and resistance levels for INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
INSPIRE MEDICAL SYSTEMS INC (INSP) has a resistance level at 95.99. Check the full technical report for a detailed analysis of INSP support and resistance levels.
Is INSPIRE MEDICAL SYSTEMS INC (INSP) expected to grow?
The Revenue of INSPIRE MEDICAL SYSTEMS INC (INSP) is expected to grow by 13.13% in the next year. Check the estimates tab for more information on the INSP EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of INSP, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of INSP, evaluating the profitability, health, valuation and growth aspects
- INSPIRE MEDICAL SYSTEMS INC (INSP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- INSPIRE MEDICAL SYSTEMS INC (INSP) Sales and EPS estimates to see what analysts future expectations are.
- INSPIRE MEDICAL SYSTEMS INC (INSP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- INSPIRE MEDICAL SYSTEMS INC (INSP) Insider and Institutional Ownership to learn about the owners and their transactions.
- INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Chart to make your own analysis
- INSPIRE MEDICAL SYSTEMS INC (INSP) Latest news and press-releases to stay up to date.
Does INSPIRE MEDICAL SYSTEMS INC (INSP) stock pay dividends?
INSP does not pay a dividend.
When does INSPIRE MEDICAL SYSTEMS INC (INSP) report earnings?
INSPIRE MEDICAL SYSTEMS INC (INSP) will report earnings on 2025-11-03, after the market close.
What is the Price/Earnings (PE) ratio of INSPIRE MEDICAL SYSTEMS INC (INSP)?
The PE ratio for INSPIRE MEDICAL SYSTEMS INC (INSP) is 40.13. This is based on the reported non-GAAP earnings per share of 2.3 and the current share price of 92.3 USD. Check the full fundamental report for a full analysis of the valuation metrics for INSP.
What is the Short Interest ratio of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The outstanding short interest for INSPIRE MEDICAL SYSTEMS INC (INSP) is 9.03% of its float. Check the ownership tab for more information on the INSP short interest.
INSP Technical Analysis
INSP Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to INSP. INSP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
INSP Financial Highlights
Over the last trailing twelve months INSP reported a non-GAAP Earnings per Share(EPS) of 2.3. The EPS increased by 1177.78% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.17% | ||
| ROA | 6.62% | ||
| ROE | 7.84% | ||
| Debt/Equity | 0 |
INSP Forecast & Estimates
26 analysts have analysed INSP and the average price target is 151.2 USD. This implies a price increase of 63.82% is expected in the next year compared to the current price of 92.3.
For the next year, analysts expect an EPS growth of -70.47% and a revenue growth 13.13% for INSP